[06 June 2013]
Products Affected - Description
Methoxsalen lotion and capsules, Valeant
Reason for the Shortage
Valeant states the shortage was due to a raw materials shortage.
Oxsoralen lotion, Valeant
1% topical lotion, 1 ounce bottle (NDC 00187-0402-31)
Oxsoralen Ultra capsules, Valeant
10 mg capsules, package of 50 (NDC 00187-0650-42)
Estimated Resupply Dates
All presentations are available.
June 6, 2013; April 23, 2013; February 28, 2013; January 25, 2013; November 14, 2012; September 4, 2012; August 8, 2012; April 6, 2012; February 8, 2012; November 30, 2011; September 28, 2011; July 26, 2011; June 16, 2011; March 8, 2011; February 2 2011; December 14, 2010; October 12, 2010; August 16, 2010; June 18, 2010; April 13, 2010; March 17, 2010; February 22, 2010; December 9, 2009; September 17, 2009, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins